Are all intracranial mass lesions always a contraindication for thrombolytic therapy?
HONG KONG JOURNAL OF EMERGENCY MEDICINE, vol.21, no.2, pp.98-102, 2014 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 21 Issue: 2
- Publication Date: 2014
- Doi Number: 10.1177/102490791402100212
- Journal Name: HONG KONG JOURNAL OF EMERGENCY MEDICINE
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.98-102
- Keywords: Adult, cardiogenic shock, meningioma, pulmonary embolism, treatment outcome
- Open Archive Collection: AVESIS Open Access Collection
- Dokuz Eylül University Affiliated: Yes
Abstract
Thrombolytic therapy, is regarded as the first treatment choice in haemodynamically unstable patients with pulmonary embolism. Intracranial tumors have long been considered as a contraindication to thrombolytic therapy due to the risk of intracerebral haemorrhage. In this report, we presented a 76-year-old female patient with meningioma and massive pulmonary embolism who had received thrombolytic therapy despite a contraindication of intracranial mass. The patient completed the thrombolytic therapy without having complication.